Smallpox - Pipeline Review, H2 2014
Summary
Global Markets Direct's, 'Smallpox - Pipeline Review, H2
2014', provides an overview of the Smallpox's therapeutic pipeline.
This report provides comprehensive information on the
therapeutic development for Smallpox, complete with comparative analysis at various
stages, therapeutics assessment by drug target, mechanism of action (MoA),
route of administration (RoA) and molecule type, along with latest updates, and
featured news and press releases. It also reviews key players involved in the
therapeutic development for Smallpox and special features on late-stage and
discontinued projects.
Global Markets Direct's report features investigational
drugs from across globe covering over 20 therapy areas and nearly 3,000
indications. The report is built using data and information sourced from Global
Markets Direct's proprietary databases, Company/University websites, SEC
filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources, put together
by Global Markets Direct's team. Drug profiles/records featured in the report
undergoes periodic updation following a stringent set of processes that ensures
that all the profiles are updated with the latest set of information.
Additionally, processes including live news & deals tracking, browser based
alert-box and clinical trials registries tracking ensure that the most recent
developments are captured on a real time basis.
The report enhances decision making capabilities and help to
create effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
For More Information visit http://www.radiantinsights.com/research/smallpox-pipeline-review-h2-2014
Note*: Certain sections in the report may be
removed or altered based on the availability and relevance of data for the
indicated disease.
Scope
- The report provides a snapshot of the global therapeutic
landscape of Smallpox
- The report reviews key pipeline products under drug
profile section which includes, product description, MoA and R&D brief,
licensing and collaboration details & other developmental activities
- The report reviews key players involved in the
therapeutics development for Smallpox and enlists all their major and minor
projects
- The report summarizes all the dormant and discontinued
pipeline projects
- A review of the Smallpox products under development by
companies and universities/research institutes based on information derived
from company and industry-specific sources
- Pipeline products coverage based on various stages of
development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination
therapy pipeline projects
- Coverage of the Smallpox pipeline on the basis of target,
MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline
products
Reasons to buy
- Provides strategically significant competitor information,
analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product
portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus
areas of leading companies
- Identify and understand important and diverse types of
therapeutics under development for Smallpox
- Plan mergers and acquisitions effectively by identifying
key players of the most promising pipeline
- Devise corrective measures for pipeline projects by
understanding Smallpox pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing
strategies by identifying prospective partners with the most attractive projects
to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying
discontinued projects and understanding the factors that drove them from
pipeline
About Radiant Insights
Radiant Insights is a platform for companies looking to meet
their market research and business intelligence requirements. We assist and
facilitate organizations and individuals procure market research reports,
helping them in the decision making process. We have a comprehensive collection
of reports, covering over 40 key industries and a host of micro markets. In
addition to over extensive database of reports, our experienced research
coordinators also offer a host of ancillary services such as, research
partnerships/ tie-ups and customized research solutions.
For more information visit, Radiant Insights
Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
No comments:
Post a Comment